Crackdown on FDCs continues, latest ban to affect Rs 824 cr market: Study

72 pharmaceutical companies have brands that fall under banned FDCs, says one expert

Pharmaceuticals, drugs, pharma industry, medical, health, lab

Sohini Das Mumbai

Listen to This Article

The government’s ban on 14 fixed dose combination (FDC) drugs in "larger public interest" will affect around Rs 824 crore of the domestic pharmaceuticals market, said a research firm citing

Also Read

Charticle: India's dubbed content market grew at a CAGR of 60.7% in 5 years

As Singapore hangs man, these are the nations with the harshest drug laws

No plan to ban firecrackers: Environment minister Choubey tells Lok Sabha

Civil society, pesticide industry present contrasting picture on ban order

CDSCO, states begin joint checks of drug-making units across India

Air India to issue a refund to those affected by flight diversion on June 6

Mother Dairy reduces MRP of Dhara edible oil by Rs 10 per litre

Zydus receives final approval from USFDA for esomeprazole magnesium

TCS records higher attrition rate among women than male colleagues in FY23

Vistara to add 10 planes, 1,000 people this FY; shelves plan to fly to US

First Published: Jun 8 2023 | 4:20 PM IST

Explore News

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on are available only to BS Premium subscribers.

Register to